0000899243-21-033151.txt : 20210816 0000899243-21-033151.hdr.sgml : 20210816 20210816190041 ACCESSION NUMBER: 0000899243-21-033151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210812 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huang Alan CENTRAL INDEX KEY: 0001877364 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39485 FILM NUMBER: 211180418 MAIL ADDRESS: STREET 1: TANGO THERAPEUTICS, INC. STREET 2: 100 BINNEY STREET, UNIT 700 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tango Therapeutics, Inc. CENTRAL INDEX KEY: 0001819133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY ST STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 320-4900 MAIL ADDRESS: STREET 1: 100 BINNEY ST STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BCTG Acquisition Corp. DATE OF NAME CHANGE: 20200723 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-12 0 0001819133 Tango Therapeutics, Inc. TNGX 0001877364 Huang Alan C/O TANGO THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 700 CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 9.56 2021-08-12 4 A 0 169859 0.00 A 2031-08-12 Common Stock 169859 169859 D This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter. /s/ William Collins, as attorney-in-fact 2021-08-16